Diapositive PPT

36

7

66

3

30

21

82

10

46

38

56

13

40

20

0

20

40

60

80

100

Lamivudine 100 mg

Placebo

Improved

Patients

(%)

Worsened

• Ranked assessment of changes in liver necro-inflammation

• ITTm population: patients lacking either biopsy excluded

• All treatment arms for 52 weeks

71

37

8

26

Lai

Dienstag

Tassopoulos

Heathcote

Schiff

Traitement de l'hépatite B Lamivudine: amélioration de l'activité